Treatment of Helicobacter pylori Infection

作者
Colin W. Howden
出处
期刊:Journal of Clinical Gastroenterology [Lippincott Williams & Wilkins]
卷期号:31 (2): 105-106 被引量:10
标识
DOI:10.1097/00004836-200009000-00003
摘要

Treatment regimens for Helicobacter pylori infection have undergone rapid evolution in a short time. In 1998, Breuer et al., 1 from Houston, TX, U.S.A., published their findings from a survey of U.S. gastroenterologists and primary care physicians that they had conducted during 1996. They documented 103 different regimens in use. Since then, the American College of Gastroenterology (ACG) has published its recommendations about the management of H. pylori infection. 2 Among the treatment regimens specifically endorsed in the ACG guidelines were triple combinations of a proton pump inhibitor (PPI) along with clarithromycin and either amoxicillin or metronidazole. However, even these recently published guidelines now appear slightly dated. For instance, some now consider that triple regimens comprising a PPI, clarithromycin, and metronidazole should no longer be advised. 3 There are fears that resistance may develop to both clarithromycin and metronidazole in patients whose infection is not cured by a course of such treatment. Because eradication rates with PPI-based triple regimens may only be 80–83% by intent-to-treat analysis, 4 as many as one in five patients treated with a PPI, clarithromycin, and metronidazole may be at risk of developing strains of H. pylori that are resistant to both of the antimicrobials. This makes re-treatment especially difficult. However, a recent report found no amoxicillin-resistant strains of H. pylori among 316 isolates from patients in the United States. 5 For that reason, the combination of a PPI, clarithromycin, and amoxicillin should be considered first-line treatment for patients with H. pylori infection, unless they are allergic to penicillin. The Food and Drug Administration has approved triple regimen comprising either lansoprazole or omeprazole along with clarithromycin and amoxicillin. The combination of lansoprazole, clarithromycin, and amoxicillin was initially approved as a 14-day treatment. However, it was subsequently shown that similar eradication rates could be achieved using the same regimen for only 10 days. 6 The combination of omeprazole, clarithromycin, and amoxicillin is approved as a 10-day treatment. Recent surveys of gastroenterologists 7 and Internal Medicine residents 8 have found that PPI-based triple regimens given for 10 or 14 days are the most frequently prescribed for H. pylori infection. Elsewhere, including Canada 9 and Europe, 10 PPI-based triple regimens are generally prescribed for 7 days. In multinational studies including European countries and Canada, PPI-based triple regimens given for only 7 days have produced consistently high eradication rates. 11–13 In the United States, however, 7 days of treatment appears to be inadequate. 14 The explanation for this apparent difference between the United States and other countries has not been satisfactorily explained. This edition of the J Clin Gastroenterol contains a report of a study from Italy that compares two eradication regimens given for even shorter periods. 15 Dr. Catalano et al. 15 treated their patients with clarithromycin and amoxicillin in standard U.S. dosages for 5 days having pre-treated with either omeprazole or pantoprazole for 2 days. By per protocol analysis, the infection was eradicated 1 month later in 95% of the omeprazole group and 84% of the pantoprazole group—a statistically nonsignificant difference. Healing of duodenal ulcer was documented in 95% of the omeprazole group and 88% of the pantoprazole group 1 month after treatment. Thus, roughly 1 omeprazole-treated patient in 20 and 1 pantoprazole-treated patient in 12 did not have initial healing of their ulcer. After 1 year, there was 100% ulcer healing in both groups among the evaluable patients. Thus, although all ulcers eventually healed, this short treatment left some patients with persistent ulceration for longer than desirable. The investigators gave either PPI as a single morning dose rather than twice daily, which is what is generally recommended. They also pretreated their patients with either PPI for 2 days before the initiation of antibiotic treatment. This was presumably to elevate intragastric pH at the time of antibiotic intake to maximize the local antimicrobial action. In doing so, they saved their patients 2 days of antibiotic treatment and still produced eradication rates comparable to those seen elsewhere in Europe using 7-day regimens with all agents started simultaneously. However, they may also have complicated the regimen unnecessarily. When giving a relatively complex regimen of three drugs, it is probably wise to simplify it as much as possible for patients. The Italian group has shown that the two PPIs they investigated were of equivalent efficacy in these combination regimens against H. pylori and that short courses of treatment work well in Italy. However, we cannot—and should not—immediately extrapolate this to the United States.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero的应助被科研通管家采纳,获得10
刚刚
研友_VZG7GZ的应助被科研通管家采纳,获得10
刚刚
VDC的应助被辛勤芷天采纳,获得30
刚刚
刚刚
深情安青的应助被科研通管家采纳,获得10
1秒前
Jasper的应助被科研通管家采纳,获得10
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
小二郎的应助被lyyzxx采纳,获得20
1秒前
eon发布了新的文献求助10
1秒前
烟花的应助被科研通管家采纳,获得10
1秒前
无花果的应助被科研通管家采纳,获得10
1秒前
传奇3的应助被竹青采纳,获得30
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
avoidant完成签到,获得积分10
1秒前
在水一方的应助被科研通管家采纳,获得10
1秒前
慕豁完成签到,获得积分10
1秒前
传奇3的应助被科研通管家采纳,获得10
1秒前
2秒前
搜集达人的应助被科研通管家采纳,获得10
2秒前
2秒前
NexusExplorer的应助被科研通管家采纳,获得10
2秒前
乐乐的应助被刘呦呦采纳,获得10
2秒前
molihuakai的应助被科研通管家采纳,获得10
2秒前
荼蘼发布了新的文献求助10
2秒前
甘甘甘甘的应助被科研通管家采纳,获得20
2秒前
QC关闭了QC的文献求助
2秒前
2秒前
文艺的白开水完成签到,获得积分10
2秒前
烟花的应助被科研通管家采纳,获得10
2秒前
bkagyin的应助被科研通管家采纳,获得10
3秒前
老迟到的访文完成签到,获得积分10
3秒前
思源的应助被科研通管家采纳,获得10
3秒前
科目三的应助被允蓥采纳,获得10
3秒前
香蕉觅云的应助被科研通管家采纳,获得10
3秒前
搜集达人的应助被科研通管家采纳,获得10
3秒前
Doro完成签到,获得积分10
3秒前
隐形曼青的应助被科研通管家采纳,获得10
3秒前
陈早早完成签到,获得积分10
3秒前
刘懂懂完成签到,获得积分10
3秒前
易方完成签到,获得积分10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180807
求助须知:如何正确求助?哪些是违规求助? 9570895
关于积分的说明 21815089
捐赠科研通 7777155
什么是DOI,文献DOI怎么找? 3433347
关于科研通互助平台的介绍 2557613
邀请新用户注册赠送积分活动 2479317